InvestorsHub Logo
Followers 137
Posts 22855
Boards Moderated 0
Alias Born 04/08/2004

Re: BonelessCat post# 198008

Sunday, 09/24/2017 10:20:09 PM

Sunday, September 24, 2017 10:20:09 PM

Post# of 402718
LilBigKuhuna:

Your post below is completely WRONG

What you keep posting assumes uses that are theoretical and have little to no evidence of efficacy in even animals because 1) Prurisol will likely require reformulation even if the current form does show promise; 2) Abacavir and the current salt of abacavir was formulated against psoriasis and not other inflammatory diseases like arthritis; and 3) assumes things not even publicly discussed as uses and plans by IPIX scientists.

While there is an argument that Prurisol currently has a valuation ranging from 500 to 1000 million at the current stage, $10 billion is to nearly everyone premature, highly excessive and an attempt to pump the price, all of which result in exactly the opposite of the post’s and valuations intent.




The Prurisol formulation needs no changes.

The current Prurisol formulation will prove effective not only for plaque psoriasis, but also psoriatic arthritis, rheumatoid arthritis and a wide variety of othe diseases and conditions.

Your post is WRONG!!!

GOD bless,

George

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News